TickerFacts.

Drugs Made In America Acquisition Corp. (DMAA): Total Liabilities

Annual figures by period end, from SEC filings.

$7.28M
As of 2025-12-31
$9.14M
As of 2026-06-30
2024-12-31: $795.7K2025-12-31: $7.28M$7.28M
2024-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$7.28M+814.5%2026-04-15, Balance as of period end
2024-12-31$795.7Kn/a2026-04-15, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Blank Checks), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Drugs Made In America Acquisition Corp. (DMAA)2025-12-31$7.28M+814.5%
Fifth Era Acquisition Corp I (FERA)2025-12-31$14.06Mn/m
Archimedes Tech SPAC Partners II Co. (ATII)2025-12-31$8.19Mn/m
Roman DBDR Acquisition Corp. II (DRDB)2025-12-31$1.10M+263.1%
Sizzle Acquisition Corp. II (SZZL)2025-12-31$11.09Mn/m
Evolution Global Acquisition Corp (EVOX)2025-12-31$9.77Mn/a
Cal Redwood Acquisition Corp. (CRAQ)2025-12-31$9.38Mn/a
Rithm Acquisition Corp. (RAC)2025-09-30$8.10Mn/a
Jena Acquisition Corp II (JENA)2025-12-31$13.83Mn/a

Compare DMAA, FERA, ATII, DRDB side by side · Screen every company in Blank Checks ↗